What target do you utilize in clinical practice for defining disease remission in RA?
This question is part of a collaboration with RheumMadness and is specifically in reference to:
BeSt Trial
Measurement of Patient Outcomes in Arthritis
Community PollStarted
What target do you utilize in clinical practice for defining disease remission in RA?
91 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Rheumatology · University of Cincinnati
Answered on
Clinical trials have consistently shown that a treat-to-target strategy in RA achieves better outcomes than "usual care". In 2019, The American College of Rheumatology recommended four in particular: Rapid 3, DAS 28 ESR or CRP, CDAI or SDAI. Several years ago, our EMR IT team (EPIC) incorporated the...
Join for free or sign in to see the full answer